Literature DB >> 15699105

The expression and function of cathepsin E in dendritic cells.

Benjamin M Chain1, Paul Free, Patrick Medd, Claire Swetman, Alethea B Tabor, Nadia Terrazzini.   

Abstract

Cathepsin E is an aspartic proteinase that has been implicated in Ag processing within the class II MHC pathway. In this study, we document the presence of cathepsin E message and protein in human myeloid dendritic cells, the preeminent APCs of the immune system. Cathepsin E is found in a perinuclear compartment, which is likely to form part of the endoplasmic reticulum, and also a peripheral compartment just beneath the cell membrane, with a similar distribution to that of Texas Red-dextran within 2 min of endocytosis. To investigate the function of cathepsin E in processing, a new soluble targeted inhibitor was synthesized by linking the microbial aspartic proteinase inhibitor pepstatin to mannosylated BSA via a cleavable disulfide linker. This inhibitor was shown to block cathepsin D/E activity in cell-free assays and within dendritic cells. The inhibitor blocked the ability of dendritic cells from wild-type as well as cathepsin D-deficient mice to present intact OVA, but not an OVA-derived peptide, to cognate T cells. The data therefore support the hypothesis that cathepsin E has an important nonredundant role in the class II MHC Ag processing pathway within dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699105     DOI: 10.4049/jimmunol.174.4.1791

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  A quantitative proteomics design for systematic identification of protease cleavage events.

Authors:  Francis Impens; Niklaas Colaert; Kenny Helsens; Bart Ghesquière; Evy Timmerman; Pieter-Jan De Bock; Benjamin M Chain; Joël Vandekerckhove; Kris Gevaert
Journal:  Mol Cell Proteomics       Date:  2010-07-13       Impact factor: 5.911

2.  Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.

Authors:  Zobeida Cruz-Monserrate; Wael R Abd-Elgaliel; Tobias Grote; Defeng Deng; Baoan Ji; Thiruvengadam Arumugam; Huamin Wang; Ching-Hsuan Tung; Craig D Logsdon
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

3.  An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity.

Authors:  Xiao-Ling Li; Heather J Ezelle; Tae-Jin Kang; Lei Zhang; Kari Ann Shirey; Janette Harro; Jeffrey D Hasday; Saroj K Mohapatra; Oswald R Crasta; Stefanie N Vogel; Alan S Cross; Bret A Hassel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

4.  Biochemical characterization and structural modeling of human cathepsin E variant 2 in comparison to the wild-type protein.

Authors:  Vida Puizdar; Tajana Zajc; Eva Zerovnik; Miha Renko; Ursula Pieper; Narayanan Eswar; Andrej Sali; Iztok Dolenc; Vito Turk
Journal:  Biol Chem       Date:  2012-03       Impact factor: 3.915

5.  Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.

Authors:  Maria Caruso; James Moore; Gregory J Goodall; Michelle Thomas; Stuart Phillis; Anna Tyskin; Glenice Cheetham; Nancy Lerda; Hiroyuki Takahashi; Andrew Ruszkiewicz
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

6.  Quantifying cathepsin S activity in antigen presenting cells using a novel specific substrate.

Authors:  Nicolas Lützner; Hubert Kalbacher
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

7.  Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.

Authors:  Jason C Kwan; Erika A Eksioglu; Chen Liu; Valerie J Paul; Hendrik Luesch
Journal:  J Med Chem       Date:  2009-09-24       Impact factor: 7.446

8.  Procathepsin E is highly abundant but minimally active in pancreatic ductal adenocarcinoma tumors.

Authors:  Anthony J O'Donoghue; Sam L Ivry; Chaity Chaudhury; Daniel R Hostetter; Douglas Hanahan; Charles S Craik
Journal:  Biol Chem       Date:  2016-09-01       Impact factor: 3.915

9.  Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice.

Authors:  Beatriz Hernandez-Novoa; Lisa Bishop; Carolea Logun; Peter J Munson; Eldad Elnekave; Zoila G Rangel; Jennifer Barb; Robert L Danner; Joseph A Kovacs
Journal:  J Leukoc Biol       Date:  2008-05-08       Impact factor: 4.962

Review 10.  Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.

Authors:  Corbin Pontious; Sabrina Kaul; Marcus Hong; Phil A Hart; Somashekar G Krishna; Luis F Lara; Darwin L Conwell; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2019-09-20       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.